Enteric fever: Difference between revisions
From IDWiki
(→) |
No edit summary |
||
Line 7: | Line 7: | ||
===Epidemiology=== |
===Epidemiology=== |
||
*Fecal-oral transmission acquired from |
*Fecal-oral transmission acquired from contaminated food, milk, or water |
||
*Less than 5% of infected people become chronic carriers, with bacteria remaining in the gallbladder despite adequate antibiotic treatment |
*Less than 5% of infected people become chronic carriers, with bacteria remaining in the gallbladder despite adequate antibiotic treatment |
||
Line 21: | Line 21: | ||
*Most commonly presents as [[fever in the returned traveller]] |
*Most commonly presents as [[fever in the returned traveller]] |
||
*Incubation period [[Usual incubation period::5 to 21 days]] |
*Incubation period [[Usual incubation period::5 to 21 days]] |
||
*Symptoms progress over weeks |
|||
* |
**First week: [[Causes::fever]], [[Causes::chills]], [[Causes::bacteremia]], [[Causes::relative bradycardia]], [[Causes::headache]] |
||
* |
**Second week: [[Causes::abdominal pain]], and a blanchable [[Causes::papular rash]] ("rose spots") may appear |
||
**Third week: can progress to gastrointestinal perforation, hepatosplenomegaly, GI bleed, secondary bacteremia |
|||
*[[Causes::Constipation]] is more common in adults, while [[Causes::diarrhea]] is more common in children and people with [[HIV]] |
|||
*CBC shows [[Causes::leukopenia]] and [[Causes::anemia]] |
|||
*Extraintestinal manifestations are myriad |
*Extraintestinal manifestations are myriad |
||
**[[ |
**[[Myelitis]], [[psychosis]], [[ataxia]], [[parkinsonism]] |
||
**[[Meningoencephalopathy]] |
|||
**[[abscess]] or [[empyema]] |
|||
**[[Endocarditis]], [[myocarditis]], and [[pericarditis]] |
**[[Endocarditis]], [[myocarditis]], and [[pericarditis]] |
||
**[[Pneumonia]] |
**[[Pneumonia]] |
||
Line 37: | Line 43: | ||
==Management== |
==Management== |
||
*Treatment with third-generation cephalosporins like [[Is treated by::ceftriaxone]] |
*Treatment with third-generation cephalosporins like [[Is treated by::ceftriaxone]], stepped down to oral when improving and susceptibility data are available |
||
**Alternatives are [[Is treated by::azithromycin]], followed by [[ampicillin]], [[TMP-SMX]], [[chloramphenicol]] |
|||
*Avoid fluoroquinolones due to high resistance rate |
**Avoid fluoroquinolones due to high resistance rate |
||
*Duration 10 to 14 days |
|||
**Can take 4 to 6 days to defervesce, even with treatment |
|||
*Monitor for relapse 2 to 3 weeks after treatment ends |
|||
[[Category:Gram-negative bacilli]] |
[[Category:Gram-negative bacilli]] |
Revision as of 11:27, 23 August 2020
Background
Microbiology
- Caused by Salmonella enterica subsp. typii and paratyphii
- Virulence is related to Vi antigen and invasin protein
Epidemiology
- Fecal-oral transmission acquired from contaminated food, milk, or water
- Less than 5% of infected people become chronic carriers, with bacteria remaining in the gallbladder despite adequate antibiotic treatment
Pathophysiology
- Induction of pH-shock proteins and other adaptions allow ingested bacteria to pass through the stomch and into the small intestine
- There, they penetrate the intestinal mucosa followed by mononuclear cells, which transport them to lypmh nodes
- They multiple within the reticuloendothelial system during the incubation period
- After a threshold is reached, they disseminate to blood
Clinical Manifestations
- Most commonly presents as fever in the returned traveller
- Incubation period 5 to 21 days
- Symptoms progress over weeks
- First week: fever, chills, bacteremia, relative bradycardia, headache
- Second week: abdominal pain, and a blanchable papular rash ("rose spots") may appear
- Third week: can progress to gastrointestinal perforation, hepatosplenomegaly, GI bleed, secondary bacteremia
- Constipation is more common in adults, while diarrhea is more common in children and people with HIV
- CBC shows leukopenia and anemia
- Extraintestinal manifestations are myriad
Diagnosis
- Blood cultures (large volume, like x4), stool cultures, bone marrow
- Biopsy (most sensitive)
Management
- Treatment with third-generation cephalosporins like ceftriaxone, stepped down to oral when improving and susceptibility data are available
- Alternatives are azithromycin, followed by ampicillin, TMP-SMX, chloramphenicol
- Avoid fluoroquinolones due to high resistance rate
- Duration 10 to 14 days
- Can take 4 to 6 days to defervesce, even with treatment
- Monitor for relapse 2 to 3 weeks after treatment ends